Literature DB >> 300481

Macromolecular factor VIII complex: functional and structural heterogeneity observed in von Willebrand swine with transfusion.

T R Griggs, J S Potter, S B McClanahan, W P Webster, K M Brinkhous.   

Abstract

The physiologic activities concerned with hemostasis and associated with the Factor VIII macromolecular complex were investigated in swine with von Willebrand's disease after infusion of cryoprecipitate, a lyophilized Factor VIII concentrate, or porcine serum. Immediately after each infusion the various activities antihemophilic factor, von Willebrand platelet aggregating factor, and Factor VIII-related antigen, were elevated in approximate proportion to dose and the bleeding time was shortened.There was a late secondary rise in antihemophilic factor. During the period after infusion, there was a differential fall-off of the various activities, with the bleeding time effect lost first, followed by the von Willebrand platelet aggregating factor and then by the Factor VIII-related antigen. The plasma from swine with von Willebrand's disease late after infusion contained high levels of antihemophilic factor without other detectable activities of the complex. Antihemophilic factor, free of the other components, obtained from plasma from swine with von Willebrand's disease either before or late after infusion eluted from agarose gel columns both as high and lower molecular weight material, unlike normal antihemophilic factor, which had a high molecular weight. In contrast, on ultracentrifugation the antihemophilic factor in these plasma sedimented slowly, even though chromatographically the plasmas contained both high and low molecular weight factor. All of the Factor VIII complex activities in normal porcine plasma sedimented rapidly. These studies demonstrate the heterogeneity of the Factor VIII complex and the apparent dependence of its chromatographic and sedimentation behavior on the functional activities associated with the complex.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300481      PMCID: PMC392373          DOI: 10.1073/pnas.74.2.759

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  ANTIHEMOPHILIC FACTOR LEVELS IN BLEEDER SWINE FOLLOWING INFUSIONS OF PLASMA AND SERUM.

Authors:  M E MUHRER; E LECHLER; C N CORNELL; J L KIRKLAND
Journal:  Am J Physiol       Date:  1965-03

2.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

3.  Properties of post-infusion factor VIII in von Willebrand's disease.

Authors:  R H Muntz; H Ekert; H Helliger
Journal:  Thromb Res       Date:  1974-08       Impact factor: 3.944

4.  Transfusion and gel filtration studies in von Willebrand's disease.

Authors:  P B Kernoff; C R Rizza; A C Kaelin
Journal:  Br J Haematol       Date:  1974-11       Impact factor: 6.998

5.  Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.

Authors:  T R Griggs; H A Cooper; W P Webster; R H Wagner; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

6.  Von Willebrand disease "stimulating factor" in porcine plasma.

Authors:  J Y Chan; C A Owen; E J Bowie; P Didisheim; J H Thompson; M E Muhrer; P E Zollman
Journal:  Am J Physiol       Date:  1968-05

7.  Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities.

Authors:  P M Blatt; K M Brinkhous; H R Culp; J S Krauss; H R Roberts
Journal:  JAMA       Date:  1976-12-13       Impact factor: 56.272

8.  The subunit structure of normal and hemophilic factor VIII.

Authors:  G A Shapiro; J C Andersen; S V Pizzo; P A McKee
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

9.  Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia.

Authors:  B Bennett; O D Ratnoff; J Levin
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

10.  Von Willebrand factor: gene dosage relationships and transfusion response in bleeder swine--a new bioassay.

Authors:  T R Griggs; W P Webster; H A Cooper; R H Wagner; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

View more
  6 in total

1.  Nonhuman primate model of polytraumatic hemorrhagic shock recapitulates early platelet dysfunction observed following severe injury in humans.

Authors:  Leasha J Schaub; Hunter B Moore; Andrew P Cap; Jacob J Glaser; Ernest E Moore; Forest R Sheppard
Journal:  J Trauma Acute Care Surg       Date:  2017-03       Impact factor: 3.313

2.  Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein.

Authors:  H A Cooper; K J Clemetson; E F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

3.  Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.

Authors:  J Over; J J Sixma; M H Bruïne; M C Trieschnigg; R A Vlooswijk; N H Beeser-Visser; B N Bouma
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

4.  Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion.

Authors:  M S Read; R L Reddick; A P Bode; D A Bellinger; T C Nichols; K Taylor; S V Smith; D K McMahon; T R Griggs; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

5.  Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin.

Authors:  K M Brinkhous; D S Barnes; J Y Potter; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

6.  Porcine and canine von Willebrand factor and von Willebrand disease: hemostasis, thrombosis, and atherosclerosis studies.

Authors:  Timothy C Nichols; Dwight A Bellinger; Elizabeth P Merricks; Robin A Raymer; Mark T Kloos; Natalie Defriess; Margaret V Ragni; Thomas R Griggs
Journal:  Thrombosis       Date:  2011-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.